UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021428
Receipt number R000024719
Scientific Title Triple-branched stent-in-stent placement for inoperable high-grade malignant hilar biliary strictures for which bilateral metal stenting has failed
Date of disclosure of the study information 2016/03/10
Last modified on 2016/03/10 22:57:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Triple-branched stent-in-stent placement for inoperable high-grade malignant hilar biliary strictures for which bilateral metal stenting has failed

Acronym

Triple metallic stent-in-stenting for malignant hilar strictures

Scientific Title

Triple-branched stent-in-stent placement for inoperable high-grade malignant hilar biliary strictures for which bilateral metal stenting has failed

Scientific Title:Acronym

Triple metallic stent-in-stenting for malignant hilar strictures

Region

Asia(except Japan)


Condition

Condition

high-grade malignant hilar biliary strictures

Classification by specialty

Gastroenterology Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the technical feasibility and efficacy of endoscopic triple-branched cross-wired metal stent-in-stent placement in patients with inoperable high-grade malignant hilar biliary strictures in whom bilateral stent-in-stent had failed clinically.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The technical success rate of triple-branched stent-in-stent placement: appropriate placement of third metal stent through prior-placed metal stents in bilaterally stent-in-stent fashion.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Endoscopic biliary metal stenting

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

17 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Histologically proven inoperable malignant hilar biliary strictures
2. Disease of Bismuth class type III or IV
3. Unresolved or recurrent cholangitis after bilateral metallic stenting
4. Karnofsky index more than 30%
5. No serious or uncontrolled medical illness.

Key exclusion criteria

1. Malignant hilar biliary strictures caused by metastatic lesions
2. Atrophic liver lobe
3. Uncontrolled coagulopathy
4. Patient's refusal

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Jong Ho Moon

Organization

SoonChunHyang University School of Medicine

Division name

Digestive Disease Center and Research Institute, Department of Internal Medicine

Zip code


Address

170 Jomaru-ro, Wonmi-gu, Bucheon 14584

TEL

+82-32-621-5094

Email

jhmoon@schmc.ac.kr


Public contact

Name of contact person

1st name
Middle name
Last name Hyun Jong Choi

Organization

SoonChunHyang University School of Medicine

Division name

Digestive Disease Center and Research Institute, Department of Internal Medicine

Zip code


Address

170 Jomaru-ro, Wonmi-gu, Bucheon 14584

TEL

+82-32-621-5211

Homepage URL


Email

joseph@schmc.ac.kr


Sponsor or person

Institute

SoonChunHyang University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

No specific funding source

Organization

Division

Category of Funding Organization

Outside Japan

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 03 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2011 Year 01 Month 01 Day

Date of IRB


Anticipated trial start date

2011 Year 01 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 03 Month 10 Day

Last modified on

2016 Year 03 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024719


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name